Samsung Electronics (LON:BC94) subsidiary NeuroLogica said yesterday it won FDA 510(k) clearance for its GC85A digital radiography system.
The newly cleared ceiling x-ray unit comes with S-Vue imaging, a wireless S-Detector, mobile system control, smart stiching and other improvements, the company said.
“The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user and patient-centric innovation to healthcare to provide fast, easy and accurate diagnoses. The system’s superior image quality and ease of control will enable users to experience a new level of efficiency with a DR system designed for streamlined operation,” Neurologica chief marketing officer David Webster said in a press release.
In June, Samsung’s biotech drug making subsidiary Bioepis said it was considering an American initial public offering.
Earlier in June, Samsung announced a partnership with Medtronic to focus on developing a range of products for people with diabetes, from remote viewing of data to fully integrated mobile and wearable devices that operate with diabetes management systems
The companies will develop an app for Google (NSDQ:GOOG) Android devices that will be compatible with Medtronic‘s (NYSE:MDT) MiniMed Connect as the first project of the parnership.